Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Psychopharmacology|December 3, 2003
Subjective effects of an initial dose of nicotine nasal spray predict treatment outcomeVyga Kaufmann, Christopher Jepson, Margaret Rukstalis, et al.
Drug and Alcohol Dependence|November 26, 2003
Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counselingFreda Patterson, Christopher Jepson, Vyga Kaufmann, et al.
Annals of Internal Medicine|March 17, 2004
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trialCaryn Lerman, Vyga Kaufmann, Margaret Rukstalis, et al.
Drug and Alcohol Dependence|July 4, 2002
Mediating mechanisms for the impact of bupropion in smoking cessation treatmentCaryn Lerman, David Roth, Vyga Kaufmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Individual differences in nicotine intake per cigaretteFreda Patterson, Neal Benowitz, Peter Shields, et al.
Addictive Behaviors|November 25, 2004
Effects of different nicotine replacement therapies on postcessation psychological responsesAndrew A Strasser, Vyga Kaufmann, Christopher Jepson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trialsCaryn Lerman, Christopher Jepson, E Paul Wileyto, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 26, 2004
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counselingBradley N Collins, E Paul Wileyto, Freda Patterson, et al.
Pageof 1